Lv1
90 积分 2024-11-26 加入
OP0316 RESET-MYOSITISTM: CLINICAL TRIAL EVALUATING Rese-cel (RESECABTAGENE AUTOLEUCEL), A FULLY HUMAN, AUTOLOGOUS 4-1BB ANTI-CD19 CAR T CELL THERAPY IN IDIOPATHIC INFLAMMATORY MYOPATHIES
2小时前
求助中
Atrasentan in Patients with IgA Nephropathy
16天前
已完结
Induced pluripotent stem-cell-derived CD19-directed chimeric antigen receptor natural killer cells in B-cell lymphoma: a phase 1, first-in-human trial
1个月前
已完结
Efficacy and safety of relmacabtagene autoleucel, an anti-CD19 chimeric antigen receptor T cell, in relapsed/refractory B-cell non-Hodgkin’s lymphoma: 2-year results of a phase 1 trial
1个月前
已完结
A phase 2 study of axicabtagene ciloleucel in relapsed or refractory large B-cell lymphoma in Japan: 1-year follow-up and biomarker analysis
1个月前
已完结
CD19-Directed CAR-T Therapy for Transformed Follicular Lymphoma: A CIBMTR Analysis
1个月前
已完结
CAR T-cell Therapy in SLE: A Systematic Review
1个月前
已完结
POS0656 TOLERABILITY AND EFFICACY OF BMS-986353 (CC-97540), A CD19-DIRECTED CHIMERIC ANTIGEN RECEPTOR (CAR) T CELL THERAPY MANUFACTURED USING A NEXT-GENERATION PROCESS FOR SYSTEMIC SCLEROSIS: UPDATED DATA FROM THE PHASE 1 BREAKFREE-1 STUDY
2个月前
已关闭
Anti-GD2 CAR-NKT cells in relapsed or refractory neuroblastoma: updated phase 1 trial interim results
2个月前
已完结
Antigen experience history directs distinct functional states of CD8+ CAR T cells during the antileukemia response
3个月前
已完结
一种沉锂母液制备磷酸锂联产碱式碳酸镁的方法
7个月前
已采纳
基于学科理解的国内化学教学研究述评
9个月前
已采纳
围手术期非血液制品止血药物应用管理专家共识(广东)
9个月前
已采纳
皖公网安备34019202002308
